Echinaforce Forte
Herbal medicinal product with Echinacea purpurea for cold and flu symptom relief
Quick Facts about Echinaforce Forte
Key Takeaways
- Traditional herbal medicine: Echinaforce Forte is classified as a traditional herbal medicinal product; its use is based on long-standing practice, not conclusive clinical proof
- Short-term use only: Should not be taken for more than 10 consecutive days; consult a doctor if symptoms persist
- Not for autoimmune conditions: Contraindicated in people with autoimmune disorders, progressive systemic diseases, and allergy to Asteraceae plants
- Adults and adolescents 12+: Not recommended for children under 12 years of age
- Immune-modulating: May interact with immunosuppressant medications; always inform your doctor about all medicines you take
What Is Echinaforce Forte and What Is It Used For?
Echinaforce Forte is a traditional herbal medicinal product containing concentrated Echinacea purpurea extract, used for the short-term relief of symptoms of the common cold and influenza-type infections in adults and adolescents over 12 years. It is available over the counter and does not require a prescription.
Echinaforce Forte belongs to a category of herbal medicinal products that are registered based on traditional use. This means the product has a long history of use for the specified indication, but has not necessarily undergone the same rigorous clinical trials as conventional pharmaceutical medicines. The European Medicines Agency (EMA) Committee on Herbal Medicinal Products (HMPC) has issued monographs on Echinacea purpurea preparations, acknowledging their traditional use in the treatment of the common cold.
The active ingredient is derived from fresh Echinacea purpurea (purple coneflower), a flowering plant native to North America. The product uses extracts from both the aerial parts (herb) and the root of the plant. Echinacea has been used for centuries by indigenous North American communities for a variety of ailments, and it became one of the most popular herbal remedies in Europe and North America during the 20th century. Echinaforce Forte is manufactured by A.Vogel (Bioforce AG), a Swiss-based company founded by naturopath Alfred Vogel, and is available in many countries worldwide.
The Forte version of Echinaforce contains a higher concentration of Echinacea purpurea extract per tablet compared to the standard Echinaforce product. This makes it suitable for more intensive short-term use when cold or flu symptoms are already present. The standard version may be preferred for general immune support at lower doses, while the Forte formulation is designed for acute symptom relief.
Mechanism of Action
Echinacea purpurea contains several groups of biologically active compounds, including alkamides, polysaccharides, glycoproteins, and caffeic acid derivatives (such as cichoric acid and echinacoside). These compounds are thought to work synergistically to modulate the immune system. Research suggests that Echinacea preparations may stimulate innate immune function by activating macrophages and natural killer (NK) cells, and by increasing the production of cytokines including interferons and interleukins.
The alkamides found in Echinacea purpurea are of particular pharmacological interest because they are readily absorbed and have been shown to modulate the activity of the cannabinoid receptor CB2, which plays a role in immune regulation. The polysaccharides in the plant may also contribute to immune activation by interacting with toll-like receptors on immune cells. However, it is important to note that while these mechanisms have been demonstrated in laboratory studies, the clinical significance of these effects in humans remains a subject of ongoing research.
Echinaforce Forte is registered as a traditional herbal medicinal product (THMP) in many European countries. This registration pathway acknowledges at least 30 years of medicinal use (including at least 15 years within the EU), but does not require the same level of clinical evidence as conventional medicines. The product label must state that the product is based on traditional use only.
What Should You Know Before Taking Echinaforce Forte?
Before taking Echinaforce Forte, be aware that it is contraindicated in people with autoimmune disorders, progressive systemic diseases, and allergy to Asteraceae (daisy family) plants. It is not suitable for children under 12 years. Pregnant and breastfeeding women should consult a healthcare professional before use.
Contraindications
Echinaforce Forte should not be taken if you have any of the following conditions or circumstances:
- Allergy to Echinacea purpurea or other Asteraceae plants: The Asteraceae (Compositae) family includes daisies, chrysanthemums, marigolds, ragweed, and sunflowers. If you are allergic to any of these plants, you may also react to Echinacea. Allergic reactions can range from mild skin rashes to severe anaphylaxis in rare cases.
- Autoimmune disorders: Because Echinacea is thought to stimulate the immune system, it should be avoided by people with autoimmune conditions such as systemic lupus erythematosus (SLE), multiple sclerosis (MS), rheumatoid arthritis, Hashimoto's thyroiditis, or other autoimmune diseases. Immune stimulation could theoretically worsen these conditions.
- Progressive systemic diseases: Conditions such as tuberculosis, leukosis (leukaemia), collagenoses, sarcoidosis, and HIV/AIDS are contraindications. The theoretical concern is that immune modulation could interfere with the disease process or its treatment.
- Children under 12 years of age: Insufficient data exist on the safety and efficacy of Echinaforce Forte in children under 12. Some Echinacea products may be available for younger age groups, but this specific formulation is not recommended.
Warnings and Precautions
Even if you do not have one of the conditions listed above, you should be aware of several important precautions before taking Echinaforce Forte. If you are currently taking any prescription medication, especially immunosuppressants or medications metabolised by the liver, inform your doctor or pharmacist before starting this product.
If your symptoms worsen, if you develop a high fever (above 39°C / 102.2°F), or if symptoms persist beyond 10 days, you should stop taking Echinaforce Forte and consult a healthcare professional. These signs may indicate a more serious infection that requires medical evaluation and possibly antibiotic treatment.
Allergic reactions, while uncommon, can occur with Echinacea products. If you experience symptoms such as skin rash, itching, swelling of the face, lips or tongue, or difficulty breathing, discontinue use immediately and seek medical attention. People with a history of atopy (a tendency towards allergic conditions such as asthma, eczema, or hay fever) may be at increased risk of allergic reactions to Echinacea.
Pregnancy and Breastfeeding
The safety of Echinaforce Forte during pregnancy and breastfeeding has not been established through controlled clinical studies. As a precautionary measure, use during pregnancy and breastfeeding is generally not recommended unless advised by a healthcare professional. Some observational studies have not identified increased risks associated with Echinacea use during pregnancy, but the evidence is limited and insufficient to make definitive safety claims.
The World Health Organization (WHO) advises caution with herbal medicines during pregnancy and breastfeeding, as many have not been adequately studied in these populations. If you are pregnant, planning to become pregnant, or breastfeeding, consult your doctor, midwife, or pharmacist before taking Echinaforce Forte or any herbal medicine.
Do not use Echinaforce Forte as a substitute for medical treatment of serious infections. If you experience a high fever, severe sore throat, difficulty breathing, chest pain, persistent vomiting, or any symptoms that concern you, seek medical advice promptly. Common cold symptoms that do not improve within 10 days or that worsen may indicate a bacterial infection requiring antibiotics.
How Does Echinaforce Forte Interact with Other Drugs?
Echinaforce Forte may interact with immunosuppressant medications by counteracting their effects. It may also affect drugs metabolised by CYP3A4 and CYP1A2 liver enzymes. Always tell your doctor or pharmacist about all medicines you are taking, including herbal products and supplements.
Drug interactions with herbal medicines can be complex and are often not as well-characterised as interactions between conventional drugs. Echinacea purpurea preparations have been studied for their effects on cytochrome P450 enzymes, which are responsible for metabolising many medications in the liver. The results from clinical pharmacokinetic studies have been somewhat variable, but several potential interactions have been identified.
The most clinically significant interaction is with immunosuppressant drugs. Because Echinacea is thought to stimulate immune function, it could theoretically reduce the effectiveness of immunosuppressive therapy. This is particularly relevant for transplant recipients taking medications like ciclosporin, tacrolimus, or sirolimus, as well as patients on immunosuppressants for autoimmune conditions.
Major Interactions
| Drug / Drug Class | Type of Interaction | Clinical Significance |
|---|---|---|
| Immunosuppressants (ciclosporin, tacrolimus, sirolimus, azathioprine) | Pharmacodynamic antagonism – Echinacea may stimulate the immune system, counteracting immunosuppressive effects | High – Avoid concurrent use. Risk of transplant rejection or flare of autoimmune disease |
| Corticosteroids (prednisolone, methylprednisolone) at immunosuppressive doses | Pharmacodynamic antagonism – opposing effects on immune function | Moderate to High – Consult prescribing physician before use |
| Methotrexate (at immunosuppressive doses) | Pharmacodynamic antagonism – may reduce immunosuppressive efficacy | High – Avoid concurrent use |
Minor Interactions
| Drug / Drug Class | Type of Interaction | Clinical Significance |
|---|---|---|
| CYP3A4 substrates (e.g., midazolam, simvastatin, some calcium channel blockers) | Possible inhibition of CYP3A4 at intestinal level; clinical studies show variable results | Low to Moderate – Monitor for increased effects of CYP3A4 substrates |
| CYP1A2 substrates (e.g., theophylline, caffeine, clozapine) | Possible modulation of CYP1A2 activity; evidence is limited and inconsistent | Low – Clinical significance uncertain; inform prescriber |
| Warfarin and other anticoagulants | Theoretical interaction; limited clinical evidence of meaningful effect on INR | Low – Monitor INR if used concurrently; inform prescriber |
| Paracetamol (acetaminophen) | No clinically significant interaction identified | Low – Generally safe to combine for cold symptom relief |
It is important to note that the evidence for many of these interactions comes from in vitro (laboratory) studies or small pharmacokinetic studies, and the clinical significance may vary depending on the specific Echinacea preparation, dose, and duration of use. However, as a general precaution, always inform your healthcare provider about any herbal products you are taking, especially before surgery or when starting a new prescription medication.
What Is the Correct Dosage of Echinaforce Forte?
The typical dosage of Echinaforce Forte for adults and adolescents over 12 years is 1-2 tablets taken 3 times daily. Treatment should begin at the first sign of cold symptoms and should not exceed 10 consecutive days. Always follow the manufacturer's instructions on the packaging.
Echinaforce Forte dosage recommendations may vary slightly between countries due to different regulatory requirements and formulation strengths. Always follow the specific dosage instructions provided on the product packaging or patient information leaflet for your country. The following general guidelines are based on typical recommendations.
Adults
Adults (18 years and over)
Standard dose: 1–2 tablets, 3 times daily
When to start: At the onset of cold or flu symptoms
Duration: Up to 10 consecutive days maximum
Administration: Swallow tablets whole with water, preferably with or after meals
Adolescents (12–17 years)
Adolescents (12–17 years)
Standard dose: 1 tablet, 3 times daily
Duration: Up to 10 consecutive days maximum
Note: The lower adult dose is typically recommended. Parental supervision is advised.
Children
Children (under 12 years)
Not recommended. Echinaforce Forte is not intended for use in children under 12 years of age due to insufficient safety and efficacy data in this age group. Other formulations specifically designed for paediatric use may be available – consult a pharmacist or healthcare professional.
Elderly
Elderly patients (65 years and over)
Standard dose: Same as adults – 1–2 tablets, 3 times daily
Note: No specific dose adjustment is required for elderly patients. However, elderly individuals are more likely to be taking multiple medications, so particular attention should be paid to potential drug interactions, especially with immunosuppressants.
Missed Dose
If you forget to take a dose of Echinaforce Forte, simply take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a forgotten one. Missing a single dose is unlikely to affect the overall effectiveness of the treatment.
Overdose
No cases of serious overdose with Echinaforce Forte or similar Echinacea purpurea preparations have been reported in the medical literature. However, taking excessive amounts may increase the risk of gastrointestinal side effects such as nausea, stomach pain, or diarrhoea. If you accidentally take significantly more than the recommended dose and feel unwell, contact your local poison control centre or seek medical advice. As with any medication or supplement, keep Echinaforce Forte out of reach of children.
| Patient Group | Dose | Frequency | Max Duration |
|---|---|---|---|
| Adults (18+) | 1–2 tablets | 3 times daily | 10 days |
| Adolescents (12–17) | 1 tablet | 3 times daily | 10 days |
| Children (<12) | Not recommended | ||
| Elderly (65+) | 1–2 tablets | 3 times daily | 10 days |
What Are the Side Effects of Echinaforce Forte?
Echinaforce Forte is generally well tolerated. The most commonly reported side effects are mild gastrointestinal symptoms such as nausea and stomach discomfort. Allergic reactions are uncommon but can occur, particularly in people with sensitivity to Asteraceae family plants.
Like all medicines, including herbal products, Echinaforce Forte can cause side effects, although not everybody gets them. The overall incidence of side effects with Echinacea purpurea preparations is considered low based on post-marketing surveillance data and clinical studies. The following frequency categories are based on available evidence from clinical trials and pharmacovigilance reports.
If you experience any side effects not listed here, or if any of the side effects become serious, please consult your doctor, pharmacist, or other healthcare professional. You can also report side effects directly to your national medicines regulatory authority.
Common
- Nausea
- Stomach discomfort or mild abdominal pain
Uncommon
- Skin rash or itching (pruritus)
- Headache
- Dizziness
- Diarrhoea
Rare
- Allergic reactions (urticaria, facial swelling, dyspnoea)
- Angioedema
- Stevens-Johnson syndrome (extremely rare)
Not Known
- Erythema nodosum
- Immune thrombocytopenia
- Hepatotoxicity (liver damage – extremely rare, isolated case reports)
Allergic reactions to Echinacea preparations deserve particular attention. While uncommon, they can be serious. People with existing allergies, particularly to plants in the Asteraceae (daisy/composite) family, are at higher risk. Cross-reactivity has been described between Echinacea and ragweed, chrysanthemums, marigolds, and daisies. A study published in the Annals of Allergy, Asthma & Immunology reported that atopic individuals (those with a personal or family history of allergic conditions) appear to be at increased risk of allergic reactions to Echinacea.
If you experience any signs of a severe allergic reaction – including difficulty breathing, swelling of the face, lips, tongue or throat, severe skin rash, or a feeling of faintness – stop taking Echinaforce Forte immediately and seek emergency medical attention. Anaphylaxis from Echinacea is extremely rare but has been reported in post-marketing surveillance.
Stop taking Echinaforce Forte and seek emergency help if you experience: swelling of the face, lips, or tongue; difficulty breathing or swallowing; severe skin rash or hives spreading across the body; dizziness or collapse. These may be signs of a serious allergic reaction (anaphylaxis).
How Should You Store Echinaforce Forte?
Store Echinaforce Forte at room temperature (below 25°C / 77°F), in the original packaging, protected from moisture and direct sunlight. Keep out of reach of children. Do not use after the expiry date printed on the package.
Proper storage of medications, including herbal products, is essential to maintain their quality, safety, and effectiveness. Echinaforce Forte tablets should be stored under the following conditions:
- Temperature: Store at room temperature, below 25°C (77°F). Do not refrigerate or freeze unless specifically stated on the packaging.
- Moisture: Keep the tablets in their original blister packaging or container to protect them from moisture. Do not transfer tablets to a damp environment such as a bathroom cabinet.
- Light: Protect from direct sunlight and excessive heat. Store in a cool, dry place.
- Original packaging: Keep the tablets in their original packaging to protect them and to retain the product information, batch number, and expiry date.
- Children: Keep out of the sight and reach of children.
- Expiry date: Do not use Echinaforce Forte after the expiry date stated on the carton and blister pack. The expiry date refers to the last day of that month.
Do not dispose of medicines via wastewater or household waste. Ask your pharmacist about how to dispose of medicines you no longer need. Proper disposal helps protect the environment and prevents accidental ingestion by children or pets.
What Does Echinaforce Forte Contain?
Each Echinaforce Forte tablet contains a concentrated extract derived from fresh Echinacea purpurea herb (aerial parts) and root. The exact composition may vary by market, but the active ingredient is a standardised hydroethanolic extract of Echinacea purpurea.
Active Ingredient
The active substance in Echinaforce Forte is a hydroethanolic (water-ethanol) extract of fresh Echinacea purpurea (L.) Moench. The extract is prepared from two parts of the plant: the aerial parts (herb) harvested during flowering, and the root. The A.Vogel Echinaforce formulations use a specific ratio of fresh herb to root, which is proprietary to the manufacturer. The use of fresh plant material, rather than dried, is a distinguishing feature of the Echinaforce product line.
Key biologically active compounds present in the extract include:
- Alkamides (alkylamides): Lipophilic compounds that are readily absorbed and have demonstrated immunomodulatory activity in laboratory studies
- Cichoric acid: A caffeic acid derivative with reported antioxidant and antiviral properties
- Polysaccharides: High molecular weight carbohydrates that may stimulate macrophage activity and other immune cells
- Glycoproteins: Protein-sugar complexes that contribute to immune modulation
- Echinacoside: A phenylpropanoid glycoside found primarily in the root, with reported anti-inflammatory properties
Excipients (Inactive Ingredients)
The tablets also contain inactive ingredients (excipients) that serve as binding agents, fillers, and coating materials. Typical excipients may include:
- Microcrystalline cellulose
- Calcium phosphate
- Stearic acid
- Silicon dioxide
- Magnesium stearate
- Hypromellose (tablet coating)
The exact list of excipients may vary between markets. Always check the patient information leaflet included with your specific product for a complete list of ingredients. If you have known allergies or intolerances to any excipients (such as lactose intolerance or coeliac disease), review the ingredient list carefully or ask your pharmacist.
Echinaforce Forte contains Echinacea purpurea, which belongs to the Asteraceae (Compositae) plant family. This family includes ragweed, chrysanthemums, marigolds, and daisies. If you have a known allergy to any of these plants, do not take this product. The product does not typically contain gluten, lactose, or artificial colours, but formulations may vary by country – check the packaging for your specific product.
Frequently Asked Questions About Echinaforce Forte
Echinaforce Forte is a traditional herbal medicinal product used for the short-term relief of symptoms of the common cold and influenza-like infections. It contains a concentrated extract of fresh Echinacea purpurea (purple coneflower) herb and root. It is intended for adults and adolescents over 12 years and should be taken at the onset of symptoms for up to 10 consecutive days.
Echinaforce Forte contains a higher concentration of Echinacea purpurea extract per tablet compared to standard Echinaforce. The Forte version is designed for more intensive use during acute cold or flu symptoms, while the standard version may be used at lower doses. Both products use the same type of fresh plant extract from Echinacea purpurea herb and root.
There is no established clinically significant interaction between Echinaforce Forte and most common antibiotics. However, as with any combination of medicines, you should always inform your doctor or pharmacist about all products you are taking. If you require antibiotics for a bacterial infection, this suggests your condition may be more serious than a simple cold, and you should follow your doctor's guidance regarding all treatments.
Echinaforce Forte is intended for short-term use only, up to a maximum of 10 consecutive days. If your cold or flu symptoms persist beyond 10 days, or if you develop a high fever, you should stop taking the product and consult a healthcare professional. Continuous long-term use is not recommended, as the effects of prolonged immune stimulation have not been adequately studied.
Echinaforce Forte should not be taken by people with autoimmune disorders (such as lupus, multiple sclerosis, or rheumatoid arthritis), progressive systemic diseases (such as tuberculosis or sarcoidosis), or a known allergy to plants in the Asteraceae (daisy) family. It is not suitable for children under 12 years. Pregnant and breastfeeding women should consult a healthcare professional before use.
Research on Echinacea for colds has produced mixed results. A Cochrane systematic review examined multiple studies and found some evidence that certain Echinacea preparations may reduce the duration and severity of colds, but results were not consistent across all products. Echinaforce Forte is classified as a traditional herbal medicinal product, meaning its use is supported by long-standing traditional practice rather than conclusive clinical proof. Some randomised controlled trials of the A.Vogel Echinaforce product line have reported positive results, but more research is needed to draw definitive conclusions.
References
- European Medicines Agency (EMA). Committee on Herbal Medicinal Products (HMPC). European Union herbal monograph on Echinacea purpurea (L.) Moench, herba recens. EMA/HMPC/48704/2018. Available at: www.ema.europa.eu
- Karsch-Völk M, Barrett B, Kiefer D, Bauer R, Ardjomand-Woelkart K, Linde K. Echinacea for preventing and treating the common cold. Cochrane Database of Systematic Reviews. 2014;(2):CD000530. doi:10.1002/14651858.CD000530.pub3
- Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysis. The Lancet Infectious Diseases. 2007;7(7):473-480. doi:10.1016/S1473-3099(07)70160-3
- Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: a randomized, double-blind, placebo-controlled trial. Evidence-Based Complementary and Alternative Medicine. 2012;2012:841315. doi:10.1155/2012/841315
- World Health Organization (WHO). WHO monographs on selected medicinal plants. Volume 1. Geneva: WHO; 1999. Herba Echinaceae Purpureae. pp. 136-145.
- Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Safety. 2005;28(5):387-400. doi:10.2165/00002018-200528050-00003
- Gorski JC, Huang SM, Pinto A, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clinical Pharmacology & Therapeutics. 2004;75(1):89-100. doi:10.1016/j.clpt.2003.09.013
- Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experience. Annals of Allergy, Asthma & Immunology. 2002;88(1):42-51. doi:10.1016/S1081-1206(10)61978-5
- British National Formulary (BNF). Herbal medicines interactions. Available at: bnf.nice.org.uk
- National Center for Complementary and Integrative Health (NCCIH). Echinacea. National Institutes of Health (NIH). Available at: www.nccih.nih.gov
Editorial Team
This article has been written and reviewed by the iMedic Medical Editorial Team, consisting of licensed specialist physicians with expertise in clinical pharmacology and phytotherapy. All content follows international medical guidelines and the GRADE evidence framework.
iMedic Medical Editorial Team – Specialists in clinical pharmacology and herbal medicine with documented academic background and clinical experience.
iMedic Medical Review Board – Independent panel of medical experts who review all content according to EMA, WHO, and BNF guidelines.
Conflict of Interest: None. iMedic receives no commercial funding from pharmaceutical or herbal medicine companies. All content is editorially independent.
Last reviewed: | Next review due: